Werkgroep Cardiologische centra Nederland English

CLEAR Harmony 1002-040 (Klaar)

A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER LONG-TERM SAFETY AND TOLERABILITY STUDY OF ETC-1002 IN PATIENTS WITH HYPERLIPIDEMIA AT HIGH CARDIOVASCULAR RISK WHO ARE NOT ADEQUATELY CONTROLLED BY THEIR LIPID-MODIFYING THERAPY
Middel
ETC-1002
Populatie
primaire preventie coronairlijden
Fase
III
Jaar aanvang
2015
Meer informatie
ClinicalTrials.gov

Studiedirecteur

dr. W.R.M. Hermans (Cardioloog)
Tilburg, ETZ locatie Elisabeth